Req. No. 496 Page 1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
STATE OF OKLAHOMA
1st Session of the 60th Legislature (2025)
SENATE BILL 29 By: Hamilton
AS INTRODUCED
An Act relating to health care; requiring licensed
practitioners to offer pharmacogenomic test prior to
prescription of psychotropic dru gs; requiring certain
disclosures and obtainment of informed consent;
directing order and administration of pharmacogenomic
test; providing for codification; and providing an
effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA :
SECTION 1. NEW LAW A new section of law to be codif ied
in the Oklahoma Statutes as Section 7201 of Title 63, unless there
is created a duplication in numbering, reads as follows:
A. A licensed practitioner shall, prior to the pre scription of
any psychotropic drug to a patient, offer to administer a
pharmacogenomic test to the patient for the purpose of guiding the
decisions of the licensed practitioner with respect to how the
patient’s genes may react to certain medications.
B. The licensed practitioner shall, to the best of the licensed
practitioner’s knowledge, inform the patient of the efficacy of
pharmacogenomic testing. The licensed practitioner shall inform the
Req. No. 496 Page 2 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
patient of whether or not the pharmacogenomic test to be
administered is approved by the United States Food and Drug
Administration. The licensed practitioner shall obtain the
patient’s informed consent prior to ordering a pharmacogenomic test.
If the practitioner is aware of the cost of the pharmacogenomic
test, the practitioner shall provide an estimate to the patient of
such cost.
C. If a patient provides informed consent to receive a
pharmacogenomic test, the licensed practitioner shall order the
pharmacogenomic test and administer such test to the patient prior
to the prescription of any psychotropic medication.
SECTION 2. This act shall become effective November 1, 2025.
60-1-496 DC 12/16/2024 12:38:56 PM